Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf136 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Yulia Butscheid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, COVID-19, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Zurich CRPP Precision, USZ Foundation, Béatrice Ederer-Weber Foundation.
Abstract (Originalsprache)
Background
Understanding the effects of changes brought by the COVID-19 pandemic on antimicrobial resistance in P. aeruginosa (PA) is essential to inform clinical management.
Methods
This single-centre retrospective cohort study included adult inpatients with PA bacteraemia at the University Hospital Zurich between January 2014 and December 2023. The primary outcome was the association between the start of the COVID-19 pandemic and PA with multidrug resistance (MDR), defined as resistance to ≥3 of 5 antibiotic classes. We used logistic regression to adjust for age, sex and ICU treatment. Secondary outcomes included changes in resistance patterns, patient demographics and antimicrobial consumption.
Results
A total of 493 instances of PA bacteraemia in 333 patients were observed during the study period. The proportion of MDRPA declined from 21% (62/291) pre-pandemic to 9% (19/202) post-pandemic (adjusted OR 0.38, 95% CI 0.18–0.79, p = 0.01). The occurrence of MDRPA during hospitalization following an initial instance of non-MDRPA bacteraemia was rare and unlikely to happen earlier than after 2 weeks. After the start of the pandemic, we observed no MDRPA cases involving cardiovascular or pulmonary diseases and marked reductions in patients with burn injuries or organ transplants. Furthermore, ciprofloxacin and tobramycin use significantly decreased after the start of the pandemic. Overall in-hospital mortality among patients with MDRPA bacteraemia remained high (28%), with no substantial differences between time periods.
Conclusion
We observed a decline in MDRPA occurrence after the start of the COVID-19 pandemic, possibly driven by intensified infection control measures, shifts in antimicrobial use and changes in patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of General Internal Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
- Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland.
- Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Pascal M Frey, Silvio D Brugger
Förderung
- University of Zurich CRPP Precision
- USZ Foundation
- Béatrice Ederer-Weber Foundation
- Swiss National Science Foundation
Zitieren
APA
Butscheid, Y., Frey, P. M., Pfister, M., Pagani, L., Kouyos, R. D., Scheier, T. C., Staiger, W. I., Mancini, S., & Brugger, S. D. (2025). Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf136
Vancouver
Butscheid Y, Frey PM, Pfister M, Pagani L, Kouyos RD, Scheier TC, et al. Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf136
BibTeX
@article{Butscheid2025,
author = {Butscheid, Yulia and Frey, Pascal M and Pfister, Marc and Pagani, Lisa and Kouyos, Roger D and Scheier, Thomas C and Staiger, Willy I and Mancini, Stefano and Brugger, Silvio D},
title = {Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf136}
}
EUVIMED